48 Participants Needed

Pain Management for Cancer Surgery

(LapTAP Trial)

CA
AC
Overseen ByAHN Clinical Trials Contact
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests three methods to manage pain during minimally invasive cancer surgeries. The treatments compared include LapTAP (Laparoscopic Transversus Abdominis Plane Block, a pain relief technique using targeted anesthetic blocks) with or without a local anesthetic, and a local anesthetic alone. Researchers aim to determine which option best controls pain, requires the least medication, and causes the fewest side effects. Individuals scheduled for elective cancer surgeries, such as those involving the liver or stomach, who can communicate their pain levels, may be suitable for this trial. As an unphased trial, this study provides a unique opportunity to contribute to innovative pain management strategies for future patients.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on long-term opioid or pain medication, you may not be eligible to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

A previous study found the Laparoscopic Transversus Abdominis Plane Block (LapTAP) to be safe and effective, particularly for abdominal surgeries. This technique manages pain by numbing nerves in the belly area. Research shows that patients tolerate it well with few side effects.

Research indicates that local anesthetics, used to numb specific areas, are generally safe. They are commonly used in surgeries and have a strong safety record, with patients usually experiencing only minor side effects, if any.

Both treatments used in the trial have undergone prior study and are considered safe for managing pain during surgery. Participants might expect typical, mild reactions, but serious issues are rare.12345

Why are researchers excited about this trial?

Researchers are excited about the pain management techniques for cancer surgery because they explore different ways to deliver anesthesia effectively. The Laparoscopic Transversus Abdominis Plane (TAP) Block stands out because it involves numbing a specific area of nerves using a minimally invasive approach, which may lead to better pain control and quicker recovery compared to traditional methods like general anesthesia. When combined with local anesthetics, it could provide enhanced pain relief with potentially fewer side effects. These techniques offer the possibility of improving patient comfort and reducing reliance on opioids, which is a major concern in post-surgical pain management.

What evidence suggests that this trial's pain management treatments could be effective for cancer surgery?

Research shows that the Laparoscopic Transversus Abdominis Plane Block (LapTAP), one of the treatments in this trial, effectively reduces pain after minimally invasive surgeries. Studies indicate that it leads to lower pain levels, and patients often require fewer pain medications. This suggests that LapTAP may aid in a more comfortable and quicker recovery after surgery. Local anesthetics, another treatment option in this trial, provide strong pain relief during and after cancer surgeries and reduce the risk of long-term pain issues. Overall, both treatments have proven effective in managing pain in surgical patients.36789

Who Is on the Research Team?

CA

Casey Allen, MD

Principal Investigator

Allegheny Health Network

Are You a Good Fit for This Trial?

This trial is for patients with various abdominal cancers (like liver, stomach, pancreatic) who are undergoing minimally invasive surgery. Participants must be eligible for the surgical procedures and willing to have their pain management method chosen randomly.

Inclusion Criteria

My upcoming medical procedure is expected to last between 1 and 8 hours.
Patients who have provided informed consent to participate in the study
I am scheduled for a minimally invasive cancer surgery in my liver, stomach, bile ducts, pancreas, reproductive organs, or GI tract.
See 2 more

Exclusion Criteria

I am either younger than 18 or 90 years old or older.
I have liver problems or cirrhosis.
My health is severely limited by my illness.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants undergo minimally invasive oncologic surgery with one of three pain management regimens: LapTAP with LA, LapTAP only, or LA only

Surgery day
1 visit (in-person)

Post-operative Monitoring

Participants are monitored for pain scores, opioid consumption, and adverse events for 24 hours post-surgery

24 hours

Follow-up

Participants are monitored for safety and effectiveness after treatment until discharge

Up to 1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Laparoscopic Transversus Abdominis Plane Block
  • Local Anesthesia
Trial Overview The study compares three pain control methods during cancer surgery: a Laparoscopic Transversus Abdominis Plane Block with local anesthesia, the block without anesthesia, and local anesthesia alone. Patients will receive standard care and their pain levels will be monitored post-surgery.
How Is the Trial Designed?
3Treatment groups
Active Control
Group I: Laparoscopic Transversus Abdominis Plane Block with Local AnestheticActive Control2 Interventions
Group II: Laparoscopic Transversus Abdominis Plane block onlyActive Control1 Intervention
Group III: Local Anesthetic onlyActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Lead Sponsor

Trials
52
Recruited
13,000+

Published Research Related to This Trial

In a study of 66 women undergoing total abdominal hysterectomy, the combination of a transversus abdominis plane block with general anesthesia significantly reduced the consumption of opioids (remifentanil) and anesthetics (sevoflurane), indicating a more efficient pain management strategy.
Patients receiving the transversus abdominis plane block reported significantly lower pain scores and higher quality of recovery scores in the postoperative period, suggesting improved outcomes compared to those who only received general anesthesia.
[The effects of transversus abdominis plane block on analgesic and anesthetic consumption during total abdominal hysterectomy: a randomized controlled study].Karaman, T., Ozsoy, AZ., Karaman, S., et al.[2022]
In a randomized trial involving 79 patients undergoing midline laparotomy, surgeon-administered transversus abdominis plane block with bupivacaine did not significantly reduce opioid requirements compared to a placebo, with both groups requiring similar amounts of morphine in the first 24 hours post-surgery.
The study found no differences in pain scores, incidence of nausea and vomiting, or other postoperative outcomes between the bupivacaine and placebo groups, suggesting that this technique should not be considered standard practice for postoperative pain management.
A double-blinded, randomized trial comparing surgeon-administered transversus abdominis plane block with placebo after midline laparotomy in gynecologic oncology surgery.Bernard, L., Lavecchia, M., Trepanier, G., et al.[2023]
In a study involving 28 adult female patients undergoing elective gynaecological surgery, the transversus abdominis plane block with 3 mg/kg of ropivacaine resulted in peak plasma concentrations that could be potentially neurotoxic, reaching a mean of 2.54 µg/ml 30 minutes post-injection.
Despite the potential for toxicity, the plasma concentrations observed were similar to those found in other injection sites, suggesting that while caution is needed, the technique may still be safe when monitored properly.
Plasma ropivacaine concentrations after ultrasound-guided transversus abdominis plane block.Griffiths, JD., Barron, FA., Grant, S., et al.[2022]

Citations

The Efficacy of Transversus Abdominis Plane (TAP) Blocks ...TAP blocks have been shown to lower postoperative pain scores, decrease postoperative opioid consumption, decrease the need for anti-emetics, ...
Optimal Perioperative Pain Control in Minimally Invasive ...Laparoscopic Transversus Abdominis Plane block (LapTAP) has emerged as a new approach for postoperative pain control following minimally invasive surgery, ...
Transversus abdominis plane block for laparoscopic ...Evidence demonstrated that laparoscopic surgery provided similar oncologic outcomes and better post-operative recoveries with comparison to open surgery in the ...
Laparoscopic versus ultrasound-guided transversus ...Our meta-analysis will summarize all the available evidence for the effectiveness and safety of TAPB approaches for minimally invasive colorectal surgery.
5.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/33823786/
Analgesic efficacy of postoperative bilateral, ultrasound ...A postoperative bilateral, ultrasound-guided, posterior TAP block resulted in better pain management and a faster recovery in patients undergoing laparoscopic ...
Efficacy and Safety of a Surgeon-Performed Laparoscopic ...In summary, our data demonstrated the safety and efficacy of a surgeon-performed, laparoscopically guided, 4-point TAP block in robot-assisted gynecologic ...
Efficacy of Transversus Abdominis Plane Block in Patients ...This study aimed to evaluate the efficacy of transversus abdominis plane block (TAPB) in patients after laparoscopic radical cervical cancer ...
Efficacy of bupivacaine liposome transversus abdominis ...This indicates that using liposomal bupivacaine for TAP block in abdominal surgery is safe and can provide sustained analgesia for over 48 h, ...
Gastrointestinal outcomes following transversus abdominus ...This systematic review aimed to explore the relationship between intra-operative TAP block and incidence of post-operative ileus. It was ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security